Skip to main content

Hyewon Jeong

Korea University · 医学

研究室紹介

Professor Hyewon Jeong's research lab focuses on translational biomedical research, integrating genomics, systems biology, and clinical pharmacology to understand the genetic and metabolic underpinnings of complex diseases. Key research directions include identifying novel genetic markers for reproductive disorders such as polycystic ovary syndrome (PCOS), elucidating metabolic reprogramming in cancer—particularly triple-negative breast cancer—and investigating drug metabolism, pharmacokinetics, and safety profiles of therapeutics in metabolic and neuropsychiatric conditions. The lab employs multi-omics approaches and clinical trial designs to bridge molecular mechanisms with clinical applications.

genetic markersmetabolic reprogrammingpharmacokineticsPCOScancer metabolism

Research Overview

Papers
72
Total Citations
875
Papers (5y)
14
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
14total
2022
2023
2024
2025
2026
Citations per year (5y)
103total
20222023202420252026

Selected Papers

15
1
Article|100 citations·2015
Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome
Hyejin Lee, Jee-Young Oh, Yeon‐Ah Sung, Hyewon Chung, Hyung‐Lae Kim, Gwang Sub Kim, Yoon Shin Cho, Jin Taek Kim
SJR Q1Human ReproductionOA

STUDY QUESTION: Are there any novel genetic markers of susceptibility to polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: We identified a novel susceptibility locus on chromosome 8q24.2 and several moderately associated loci for PCOS in Korean women. WHAT IS KNOWN ALREADY: PCOS is a highly complex disorder with significant contributions from both genetic and environmental factors. Previous genome-wide association studies (GWAS) in the Han Chinese population identified several risk loci for PCOS

Reproductive MedicineMedicine
2
Article|59 citations·2017
Comorbidity of gynecological and non-gynecological diseases with adenomyosis and endometriosis
Eun Ji Choi, Seong Beom Cho, Sa Ra Lee, Young Mi Lim, Kyungah Jeong, Hye Sung Moon, Hyewon Chung
SJR Q2Obstetrics & Gynecology ScienceOA

We must monitor for the presence of gynecological and non-gynecological diseases with co-morbidities during evaluations and follow-up of patients with adenomyosis or endometriosis.

Reproductive MedicineMedicine
3
Article|52 citations·2009
The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome
Hyejin Lee, Jee-Young Oh, Yeon‐Ah Sung, Hyewon Chung, Wha Young Cho
SJR Q2Endocrine
Reproductive MedicineMedicine
4
Article|46 citations·2022
Nicotinamide (niacin) supplement increases lipid metabolism and ROS‐induced energy disruption in triple‐negative breast cancer: potential for drug repositioning as an anti‐tumor agent
Minsun Jung, Kyung‐Min Lee, Yebin Im, Seung Hyeok Seok, Hyewon Chung, Da-Young Kim, Dohyun Han, Cheng Hyun Lee, Eun Hye Hwang, Soo Young Park, Jiwon Koh, Bohyun Kim
SJR Q1Molecular OncologyOA

Metabolic dysregulation is an important hallmark of cancer. Nicotinamide (NAM), a water-soluble amide form of niacin (vitamin B3), is currently available as a supplement for maintaining general physiologic functions. NAM is a crucial regulator of mitochondrial metabolism and redox reactions. In this study, we aimed to identify the mechanistic link between NAM-induced metabolic regulation and the therapeutic efficacy of NAM in triple-negative breast cancer (TNBC). The combined analysis using mult

Cancer ResearchBiochemistry, Genetics and Molecular Biology
5
Article|42 citations·2021
Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
Ki Young Huh, Hyewon Chung, Yu Kyong Kim, SeungHwan Lee, Siddharth Bhatia, Yohei Takanami, Ryou Nakaya, Kyung‐Sang Yu
SJR Q1British Journal of Clinical PharmacologyOA

AIMS: Helicobacter pylori (Hp) eradication plays a key role in the treatment and prevention of peptic ulcer diseases. Increasing clarithromycin resistance in Hp necessitates more effective treatments for eradication, such as bismuth-containing quadruple therapy. We aimed to compare the safety and pharmacokinetics (PK) of bismuth between vonoprazan- and lansoprazole-containing quadruple therapy in Hp-positive subjects. METHODS: In this randomised, double-blind, parallel-group study, Hp-positive s

SurgeryMedicine
6
Article|38 citations·2015
Inhibition of the multidrug and toxin extrusion ( MATE ) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans
Jaeseong Oh, Hyewon Chung, Sang‐Cheol Park, SoJeong Yi, Kyungho Jang, Anhye Kim, Jangsoo Yoon, Joo‐Youn Cho, Seo Hyun Yoon, In‐Jin Jang, Kyung‐Sang Yu, Jae‐Yong Chung
SJR Q1Diabetes Obesity and Metabolism

We hypothesized that the pharmacodynamic (PD) characteristics of metformin would change with inhibition of the multidrug and toxin extrusion (MATE) transporter, which mediates renal elimination of metformin. Twenty healthy male subjects received two doses (750/500 mg) of metformin, with and without 50 mg of pyrimethamine (a potent MATE inhibitor), with 1 week of washout in between each dose. The PD characteristics of metformin were assessed using oral glucose tolerance tests (OGTTs) before and a

OncologyMedicine
7
Article|37 citations·2016
A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers
Anhye Kim, Kyoung Soo Lim, Howard Lee, Hyewon Chung, Seo Hyun Yoon, Kyung-Sang Yu, Joo‐Youn Cho, In‐Jin Jang, Jae‐Yong Chung
SJR Q2International Clinical Psychopharmacology

Prolongation of the QT interval on an ECG is a surrogate marker for predicting the proarrhythmic potential of a drug under development. The aim of this study was to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine immediate release (IR) and escitalopram, in healthy individuals. This was a randomized, open-label, 4×4 Williams crossover study, with four single-dose treatments [placebo, 400 mg moxifloxacin (positive control), 20 mg escitalopram, and 100 mg quetiapin

Cardiology and Cardiovascular MedicineMedicine
8
Article|36 citations·2017
Zebrafish Larvae Model of Dilated Cardiomyopathy Induced by Terfenadine
Gyo‐Jeong Gu, Yirang Na, Hyewon Chung, Seung Hyeok Seok, Hae‐Young Lee
SJR Q2Korean Circulation JournalOA

BACKGROUND AND OBJECTIVES: Dilated cardiomyopathy can be the end-stage of severe cardiac disorders and directly affects the cardiac muscle, inducing cardiomegaly and heart failure (HF). Although a wide variety of animal models are available to study dilated cardiomyopathy, there is no model to assess dilated cardiomyopathy with non-invasive, simple, and large screening methods. METHODS: We developed a dilated cardiomyopathy model in zebrafish larvae using short duration terfenadine, a known card

Cell BiologyBiochemistry, Genetics and Molecular Biology
9
Article|31 citations·2018
A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study
Hyewon Chung, Jaeseong Oh, Seo Hyun Yoon, Kyung‐Sang Yu, Joo‐Youn Cho, Jae‐Yong Chung
SJR Q1PLoS ONEOA

ClinicalTrials.gov NCT02712619.

Endocrinology, Diabetes and MetabolismMedicine
10
Article|30 citations·2021
Comparative pharmacokinetics of Theracurmin, a highly bioavailable curcumin, in healthy adult subjects
Hyewon Chung, Seo Hyun Yoon, Joo‐Youn Cho, Hee Kyung Yeo, Dongseong Shin, Jiyoung Park
SJR Q3International Journal of Clinical Pharmacology and TherapeuticsOA

In conclusion, this study showed similar systemic exposure between the two Theracurmin products. The absorption of curcumin after the administration of Theracurmin was significantly enhanced compared with curcumin powder.

Molecular MedicineBiochemistry, Genetics and Molecular Biology
11
Article|26 citations·2015
A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles
Hyewon Chung, Howard Lee, HyeKyung Han, Hyungmi An, Kyoung Soo Lim, Yongjin Lee, Joo‐Youn Cho, Seo Hyun Yoon, In‐Jin Jang, Kyung‐Sang Yu
SJR Q1Drug Design Development and TherapyOA

SYP-1018 had comparable pharmacokinetic and tolerability profiles to Vfend(®) after a single intravenous infusion. CYP2C19 genotype affected not only the pharmacokinetics of voriconazole, but its intrasubject variability. SYP-1018 can be further developed as a clinically effective alternative to Vfend(®).

Infectious DiseasesMedicine
12
Article|17 citations·2018
Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients
Hyewon Chung, Kyung Taek Hong, Ji Won Lee, Su‐jin Rhee, S. Kim, Seo Hyun Yoon, Kyung‐Sang Yu, Hyoung Jin Kang
SJR Q1Bone Marrow Transplantation
Public Health, Environmental and Occupational HealthMedicine
13
Article|16 citations·2017
A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug Monitoring
Hyewon Chung, Kyung‐Sang Yu, Kyung Taek Hong, Jung Yoon Choi, Che Ry Hong, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, SeungHwan Lee
SJR Q2Therapeutic Drug Monitoring

Busulfan is a cytotoxic agent used in preconditioning for hematopoietic stem cell transplantation. Therapeutic drug monitoring of busulfan is necessary owing to its narrow therapeutic range. Patients undergoing preconditioning are susceptible to infection and might require coadministration of antibiotics. We present a case study of a 3-year-old girl with precursor T-cell acute lymphoblastic leukemia who received intravenous busulfan before hematopoietic stem cell transplantation. Metronidazole w

PharmacologyMedicine
14
Article|12 citations·2007
Disseminated Histoplasmosis and Tuberculosis in a Patient with HIV Infection
정혜원, 손장욱, 김민자, 최정우, 김철환, 최상호, 김지용, 조윤정
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0311120070480030531

Histoplasmosis is a very rare disease in Korea. Clinical manifestations are very similar to those of tuberculosis. This is the first case report of combined disseminated histoplasmosis and tuberculosis in a patient with HIV infection in Korea. A 42-year-old Korean with Acquired Immunodeficiency Syndrome (AIDS) was diagnosed with tuberculosis. He had lived in Guatemala for the past five years. Upon diagnosis of disseminated tuberculosis with HIV infection, he was treated with anti-tuberculosis me

15
Article|4 citations·2023
Effects of Simvastatin on Pharmacokinetics and Anticoagulant Effects of Dabigatran in Healthy Subjects
Hyewon Chung, Jong-Min Kim, Jin‐Woo Park, Jin‐Woo Park, Jihyeon Noh, Kyoung‐Ah Kim, Ji Young Park, Ji Young Park
SJR Q1PharmaceuticalsOA

Higher risk of major hemorrhage associated with concomitant use of dabigatran and simvastatin compared to other statins was previously reported with a suggestion of P-glycoprotein-mediated interaction. The aim of this study was to evaluate the effects of simvastatin on pharmacokinetics and anticoagulant effects of dabigatran, a direct oral anticoagulant. A total of 12 healthy subjects were enrolled in an open-label, two-period, single sequence study. Subjects were given 150 mg of dabigatran etex

SurgeryMedicine

Research Areas

Cardiology and Cardiovascular MedicineReproductive MedicineSurgeryImmunologyOncologyEndocrinology, Diabetes and Metabolism

Hyewon Jeongの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。